Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$85.07 - $94.48 $249,084 - $276,637
2,928 New
2,928 $259,000
Q3 2021

Nov 10, 2021

SELL
$74.77 - $85.47 $448 - $512
-6 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$72.61 - $90.2 $871 - $1,082
-12 Reduced 66.67%
6 $1,000
Q3 2020

Nov 12, 2020

SELL
$71.87 - $131.03 $2,731 - $4,979
-38 Reduced 67.86%
18 $1,000
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $3,261 - $5,093
41 Added 273.33%
56 $7,000
Q4 2019

Feb 12, 2020

BUY
$64.27 - $86.37 $964 - $1,295
15 New
15 $1,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.